Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IC0624 as First-Line Therapy in Mild to Moderate Hidradenitis Suppurativa
2024-518180-35-00Phase 2Completed
- Sponsor
- Ichthyol-Gesellschaft Cordes, Hermanni & Co.
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hidradenitis suppurativa (HS) comparing Ichthraletten with Placebo (2 arms). Primary endpoint: HiSCR50 at week 6. Started Feb 2025; status: completed.
02
Drugs
sodium bituminosulfonate
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on 2024-518180-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518180-35-00.